These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23607598)

  • 1. Involvement of high mobility group box 1 and the therapeutic effect of recombinant thrombomodulin in a mouse model of severe acute respiratory distress syndrome.
    Kudo D; Toyama M; Aoyagi T; Akahori Y; Yamamoto H; Ishii K; Kanno E; Maruyama R; Kaku M; Kushimoto S; Kawakami K
    Clin Exp Immunol; 2013 Aug; 173(2):276-87. PubMed ID: 23607598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of recombinant thrombomodulin for lung injury after pneumonectomy via inhibition of high-mobility group box 1 in mice.
    Takahashi Y; Matsutani N; Dejima H; Nakayama T; Okamura R; Uehara H; Kawamura M
    J Trauma Acute Care Surg; 2016 Nov; 81(5):868-875. PubMed ID: 27504958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMGB1 suppress the expression of IL-35 by regulating Naïve CD4+ T cell differentiation and aggravating Caspase-11-dependent pyroptosis in acute lung injury.
    Xie K; Chen YQ; Chai YS; Lin SH; Wang CJ; Xu F
    Int Immunopharmacol; 2021 Feb; 91():107295. PubMed ID: 33360086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human soluble thrombomodulin prevents acute lung injury in a rat cardiopulmonary bypass model.
    Hirao S; Minakata K; Masumoto H; Yamazaki K; Ikeda T; Minatoya K; Sakata R
    J Thorac Cardiovasc Surg; 2017 Dec; 154(6):1973-1983.e1. PubMed ID: 28645823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant Thrombomodulin Attenuates Preeclamptic Symptoms by Inhibiting High-Mobility Group Box 1 in Mice.
    Oda H; Nagamatsu T; Schust DJ; Cabral H; Miyazaki T; Iriyama T; Kawana K; Osuga Y; Fujii T
    Endocrinology; 2021 Apr; 162(4):. PubMed ID: 33406229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuated accumulation of regulatory T cells and reduced production of interleukin 10 lead to the exacerbation of tissue injury in a mouse model of acute respiratory distress syndrome.
    Toyama M; Kudo D; Aoyagi T; Miyasaka T; Ishii K; Kanno E; Kaku M; Kushimoto S; Kawakami K
    Microbiol Immunol; 2018 Feb; 62(2):111-123. PubMed ID: 29266409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant thrombomodulin attenuates hyper-inflammation and glycocalyx damage in a murine model of Streptococcus pneumoniae-induced sepsis.
    Watanabe E; Akamatsu T; Ohmori M; Kato M; Takeuchi N; Ishiwada N; Nishimura R; Hishiki H; Fujimura L; Ito C; Hatano M
    Cytokine; 2022 Jan; 149():155723. PubMed ID: 34662822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of high-mobility group box 1 and thrombin in murine pulmonary fibrosis and the therapeutic potential of thrombomodulin.
    Kida T; Seno T; Nagahara H; Inoue T; Nakabayashi A; Kukida Y; Fujioka K; Fujii W; Wada M; Kohno M; Kawahito Y
    Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L473-L483. PubMed ID: 29212801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble recombinant human thrombomodulin suppresses inflammation-induced gastrointestinal tumor growth in a murine peritonitis model.
    Amada E; Fukuda K; Kumagai K; Kawakubo H; Kitagawa Y
    Mol Cell Biochem; 2020 Dec; 475(1-2):195-203. PubMed ID: 32767229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGB1 regulates IL-33 expression in acute respiratory distress syndrome.
    Fu J; Lin SH; Wang CJ; Li SY; Feng XY; Liu Q; Xu F
    Int Immunopharmacol; 2016 Sep; 38():267-74. PubMed ID: 27318792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of circulating monocytes suppresses IL-17 and HMGB1 expression in mice with LPS-induced acute lung injury.
    Jiang Z; Zhou Q; Gu C; Li D; Zhu L
    Am J Physiol Lung Cell Mol Physiol; 2017 Feb; 312(2):L231-L242. PubMed ID: 27913426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethyl pyruvate ameliorates acute respiratory distress syndrome in mice.
    Mićanović D; Lazarević M; Kulaš J; Despotović S; Stegnjaić G; Jevtić B; Koprivica I; Mirkov I; Stanisavljević S; Nikolovski N; Miljković Đ; Saksida T
    Eur J Pharmacol; 2024 May; 971():176509. PubMed ID: 38493914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Modulation of Regulatory T Cells via HMGB1/PTEN/β-Catenin Axis in LPS Induced Acute Lung Injury.
    Zhou M; Fang H; Du M; Li C; Tang R; Liu H; Gao Z; Ji Z; Ke B; Chen XL
    Front Immunol; 2019; 10():1612. PubMed ID: 31402909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro effects of the anticoagulant, thrombomodulin, on the inflammatory response in rodent models.
    Hagiwara S; Iwasaka H; Matsumoto S; Hasegawa A; Yasuda N; Noguchi T
    Shock; 2010 Mar; 33(3):282-8. PubMed ID: 19536047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMGB1 aggravates lipopolysaccharide-induced acute lung injury through suppressing the activity and function of Tregs.
    Li R; Zhang J; Pan S; Yuan Y; Qi H; Shu H; Hu Y; Ren L; Jiang Y; Yuan S
    Cell Immunol; 2020 Oct; 356():104192. PubMed ID: 32853967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose interferon-α treatment improves survival and inflammatory responses in a mouse model of fulminant acute respiratory distress syndrome.
    Kudo D; Uno K; Aoyagi T; Akahori Y; Ishii K; Kanno E; Maruyama R; Kushimoto S; Kaku M; Kawakami K
    Inflammation; 2013 Aug; 36(4):812-20. PubMed ID: 23407996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble thrombomodulin attenuates sinusoidal obstruction syndrome in rat through suppression of high mobility group box 1.
    Nakamura K; Hatano E; Miyagawa-Hayashino A; Okuno M; Koyama Y; Narita M; Seo S; Taura K; Uemoto S
    Liver Int; 2014 Nov; 34(10):1473-87. PubMed ID: 24498917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant thrombomodulin ameliorates experimental autoimmune encephalomyelitis by suppressing high mobility group box 1 and inflammatory cytokines.
    Uzawa A; Mori M; Masuda H; Ohtani R; Uchida T; Kuwabara S
    Clin Exp Immunol; 2018 Jul; 193(1):47-54. PubMed ID: 29509323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human soluble thrombomodulin improved lipopolysaccharide/d-galactosamine-induced acute liver failure in mice.
    Osumi W; Jin D; Imai Y; Tashiro K; Li ZL; Otsuki Y; Maemura K; Komeda K; Hirokawa F; Hayashi M; Takai S; Uchiyama K
    J Pharmacol Sci; 2015 Dec; 129(4):233-9. PubMed ID: 26712705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human thrombomodulin for pneumonia-induced severe ARDS complicated by DIC in children: a preliminary study.
    Hirata N; Ngo DT; Phan PH; Ainai A; Phung TTB; Ta TA; Takasaki J; Kawachi S; Nunoi H; Nakajima N; Dien TM
    J Anesth; 2021 Oct; 35(5):638-645. PubMed ID: 34259911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.